Partial Response to Ceritinib in a Patient With Abdominal Inflammatory Myofibroblastic Tumor Carrying a TFG-ROS1 Fusion

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2019.7360
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Partial Response to Chemotherapy in a Patient With Retroperitoneal Inflammatory Myofibroblastic Tumor

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Inflammatory Myofibroblastic Bladder Tumor With Divergent Behavior in a Patient With Spinal Cord Injury

IJU Case Reports
2019English

Inflammatory Myofibroblastic Tumor: A Rare Tumor in the Tongue

Case Reports in Otolaryngology
2013English

Retroperitoneal Inflammatory Myofibroblastic Tumor: A Case Report

European Journal of Radiology Open
Nuclear MedicineRadiologyImaging
2017English

Drastic Initial Response and Subsequent Response to Two ALK Inhibitors in a Patient With a Highly Aggressive ALK-rearranged Inflammatory Myofibroblastic Tumor Arising in the Pleural Cavity

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2016English

A Case of Pulmonary Inflammatory Myofibroblastic Tumor

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2009English

Maxillary Inflammatory Myofibroblastic Tumor

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2016English

Ceritinib Beim ROS1-positiven NSCLC

Im Focus Onkologie
2017English

A Case of Rectal Inflammatory Myofibroblastic Tumor Associated With Intraabdominal Hemorrhage

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy